Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

A randomized, double-blind multicenter 2-stage phase III study of bevacizumab in combination with cisplatin and gemcitabine versus placebo, cisplatin and gemcitabine in patients with advanced or recurrent non-squamous non-small cell lung cancer, who have not received prior chemotherapy
bevacizumab
BO17704 (AVAIL)
NCT00806923
locally advanced metastatic or recurrent non-squamous non-small cell lung cancer
Phase 3
 
January 2014

Powered by ideaPoint, Inc.